Argenx announces approval of vyvdura (efgartigimod alfa and hyaluronidase-qvfc) in japan for adults with chronic inflammatory demyelinating polyneuropathy

Vyvdura ® now approved for at-home self-injection in japan for both generalized myasthenia gravis and cidp

ARGX Ratings Summary

ARGX Quant Ranking